MANGALAM Intraday Analysis...

MANGALAM Share Price

Open 142.55 Change Price %
High 144.70 1 Day N/A N/A
Low 135.95 1 Week 0.00 0.00
Close 137.80 1 Month 0.00 0.00
Volume 54522 1 Year 0.00 0.00
52 Week High 0.00
52 Week Low 0.00
MANGALAM Important Levels
Resistance 2 0.00
Resistance 1 0.00
Pivot 0.00
Support 1 0.00
Support 2 0.00
NSE INDIA Most Active Stocks
RCOM 14.30 %
IFCI 18.90 %
JPASSOCIAT 16.10 %
IDEA 59.75 %
PFC 75.55 %
PFC 75.55 %
PFC 75.55 %
VEDL 251.80 %
GMRINFRA 17.90 %
ADANIPOWER 20.05 %
More..
NSE INDIA Top Gainers Stocks
More..
NSE INDIA Top Losers Stocks
More..

Mangalam Drugs And Organics Limited (NSE: MANGALAM)

MANGALAM Technical Analysis 1
As on 25th May 2018 MANGALAM Share Price closed @ 137.80 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
MANGALAM Target for May
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Mangalam Drugs And Organics Limited ( NSE INDIA Symbol : MANGALAM )
Sector : Pharmaceuticals And Other Stocks in Same Sector
MANGALAM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 20.24 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 149.80
10 Day Avg Volume Traded 24.64 % More then 10 Day Average Volume
MANGALAM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
MANGALAM Address
MANGALAM
N/A
MANGALAM Latest News
Mangalam Drugs And Organics Limited   Moneycontrol.com   - 19th Mar 15
Clarification sought from Mangalam Drugs & Organics Ltd   Hindu Business Line   - 19th Mar 15
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 17th Feb 15
Mangalam Drugs' director Rajendra Prasad Mimani resigns   Moneycontrol.com   - 03rd Feb 15
They lied to me for 15 years of my life, says asbestosis-afflicted labourer   Mid-Day   - 21st Jul 14
Fire stops work at Mangalam Organics plant in Maharastra   Business Standard   - 07th Feb 14
CRISIL ratings for Indian debt instruments-Feb 4   Reuters   - 04th Feb 14
Dujodwala Products changes its name to Mangalam Organics   Moneycontrol.com   - 05th Nov 13
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011   Hindu Business Line   - 09th Apr 12
Indian takeovers abroad   The Economist   - 01st Mar 12
Interactive Technical Analysis Chart Mangalam Drugs And Organics Limited ( MANGALAM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Mangalam Drugs And Organics Limited
MANGALAM Business Profile
Mangalam Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 5.57 crore.The company has reported a standalone sales of Rs 28.21 crore and a Net Loss of Rs 0.97 crore for the quarter ended Sep 2013.The company management includes Govardhan M Dhoot - Chairman, Subhash C Khattar - Ind. Non-Executive Director, Rajendraprasad Mimani - Ind. Non-Executive Director. It is listed on the BSE with a BSE Code of 532637 and the NSE with an NSE Code of MANGALAM.Its Registered office is at No 292, Princess Street, 2nd Floor, Near Flyover,,Marine Lines Mumbai,Maharashtra - 400002.Their Registrars are Link Intime India Pvt. Ltd.